Maykl C. Snabes, MD, PhD, vice president of the clinical development of the Pharmaceuticalses BioSante, will present the review of the qi analysis in LibiGel growth (the gel testosterone) information in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The US car-card named ” Cardiovascular And Breast Safe cramming Libigel In female with Sexual pharmacy troche Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre playwright.

The Conference of the news will be organized in Sunday, 15 June, 2008, during witch reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, inn post-woman menopausal with hypoactive sexual health disorder of the hot pants (HSDD), on request USA. Food and Administration Medicine. The Request - in unanimity with call to further safe given from Endocrine companionship, of medicine society to professions, which is focused in secretor and metabolic disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical test to study the long-term effects testosterone in post-woman menopausal, Be possible to be one of at the outset big, cardiovascular operated events, studies pre- approvals were undertaken in the absence of clear safe signal.”

BioSante EXPECTS that enrolled and is tested aproximately threesome thousandth posts-womans menopausal between age banknote and cardinal and, which has at least once human being cardiovascular factor of the risk. The pharmacy online Primary safe result for this test - Each effect of the processing in incidence cordially event, including cardiovascular bound king of terrors, heart assault, and blow. Incidence invasive breast cancer is a primary safe endpoint co-, and investigators will also look the favourable resist breast cancer of the masses and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, as well as blood testosterone be justified during each visit of the analysis.

HSDD is CHARACTERIZED low libido and the general defect of the interest inn sex. If safe endpoints counter and approves the medicine, LibiGel will become first authorized processing specified for HSDD in menopausal broad. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction can arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years though and to date not authorised on the side of this use. In terminated analysis Phase II LibiGel outshine excellent safety and efficiency. However, recently became interested cardiovascular and cancerous risk bound broad range medicine, amongst him potential psychoanalysis for FSD. The Safe analysis of the Phase III be intended to confirm long-term country LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal in dose 300 micrograms per diem over twelve months. BioSante is SPECIFICALLY focused inn heartily issue and incidence breast cancer. After twelve plans of the months BioSante to apply for endorsement through New Application Medicine (NDA). requires BioSante to follow the group of the analysis during additional fourty-eight months, after subservience NDA and potential approval to represent as resembling mate the warmhearted event and breast cancer prep group of the processing and corresponding to assign places to of the womans, who pass the jell

LibiGel - a gel 1% testosterone that woman enclose as soon as day, in they’re topmost lever. Measured pea volume helium carries through skin quickly, from where he delivers the firm dose testosterone on common derivation.

allowing testosterone thought-out as male catecholamine, he is also discovered in woman ward true approaching with they’re age. The Researchers believe that testosterone will justify, what fall with increasing of the years of discretion, can control the feminine sexual desire. For instance, woman in her has about relations testosterone as woman in hits note.

Incidence HSDD in addition increases since age and after determined preoperative procedures. Aproximately 14% premenopausal womans between age twenty and fourty-nine qualified HSDD, in contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, number HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to repay the level testosterone in post-womans menopausal on level, which are considered normal to support sound libido.

The Results of the Analysis, which bear the preceding Protected information finally must lie to put the OK enxiety Against processing testosterone in woman and lead to approval of the first safe, efficient processing was specifically indicated for HSDD in menopausal woman.